Virtu KCG Holdings’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Virtu KCG Holdings’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$429K	Sell	6,829 -22,973	-77%	-$1.38M	0.01%	1291
2017 Q1	$1.75M	Sell	29,802 -17,959	-38%	-$1.05M	0.05%	326
2016 Q4	$2.68M	Buy	47,761 +25,298	+113%	+$1.46M	0.07%	191
2016 Q3	$1.39M	Buy	22,463 +9,696	+76%	+$635K	0.03%	487
2016 Q2	$809K	Sell	12,767 -276	-2%	-$17.4K	0.02%	922
2016 Q1	$784K	Sell	13,043 -15,979	-55%	-$977K	0.02%	768
2015 Q4	$2.03M	Sell	29,022 -14,292	-33%	-$1.01M	0.03%	412
2015 Q3	$2.87M	Buy	43,314 +34,670	+401%	+$2.7M	0.05%	276
2015 Q2	$677K	Buy	+8,644	New	+$673K	0.01%	1213
2014 Q2	–	Sell	-15,937	Closed	-$903K	–	3958
2014 Q1	$903K	Buy	+15,937	New	+$905K	0.01%	1328
2013 Q4	–	Sell	-9,734	Closed	-$448K	–	4138
2013 Q3	$448K	Buy	+9,734	New	+$444K	0.01%	2132

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Virtu KCG Holdings's PJP Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Invesco Pharmaceuticals ETF (PJP) stake by 77% in Q2 2017, selling an estimated $1.38M and leaving 6,829 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #1291.

Virtu KCG Holdings first reported a position in PJP in Q3 2013 and has held it in 11 quarters since. The position peaked at $2.87M in Q3 2015. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

Virtu KCG Holdings held 6,829 shares of Invesco Pharmaceuticals ETF worth $429K as of Q2 2017.
Virtu KCG Holdings sold 22,973 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $1.38M.
Invesco Pharmaceuticals ETF made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1291 holding.
Virtu KCG Holdings first reported a position in Invesco Pharmaceuticals ETF in Q3 2013 and has held it in 11 quarters since.
Virtu KCG Holdings's Invesco Pharmaceuticals ETF position peaked at $2.87M in Q3 2015.
99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.